Evommune, Inc. (EVMN)
24.11
+0.48
(+2.03%)
USD |
NYSE |
May 05, 16:00
24.11
0.00 (0.00%)
After-Hours: 20:00
Evommune EPS Diluted (Quarterly) : -0.8969 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Nektar Therapeutics | -1.778 |
| Moderna, Inc. | -3.40 |
| Apogee Therapeutics, Inc. | -1.026 |
| Vertex Pharmaceuticals, Inc. | 4.02 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.27M |
| Total Expenses (Quarterly) | 28.27M |
| Enterprise Value | 703.97M |
| Earnings Yield | -9.24% |
| Normalized Earnings Yield | -10.10 |